Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response

Effect of a Single-Cycle Alternative Dosing Regimen for Rituximab for Recalcitrant Pemphigus

(2012) Setsuko Matsukura et al.   ARCHIVES OF DERMATOLOGY

Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up

(2012) Giuseppe Cianchini et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Immunosuppressive therapy for autoimmune bullous diseases

(2011) Michael Meurer   CLINICS IN DERMATOLOGY

Current therapy of the pemphigus group

(2011) Michael Kasperkiewicz et al.   CLINICS IN DERMATOLOGY

Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris

(2011) Emma E. Craythorne et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis

(2011) M.-J. C. J. Guerry et al.   RHEUMATOLOGY

A Plasmablast Biomarker for Nonresponse to Antibody Therapy to CD20 in Rheumatoid Arthritis

(2011) K. Owczarczyk et al.   Science Translational Medicine

Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis

(2010) O. Thaunat et al.   BLOOD

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

(2010) E. P. Rhee et al.   Clinical Journal of the American Society of Nephrology

Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence

(2010) Manuel Ramos-Casals et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

(2010) Paul A. Blair et al.   IMMUNITY

The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials

(2010) Young Ho Lee et al.   RHEUMATOLOGY INTERNATIONAL

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

(2009) Thomas Dörner et al.   AUTOIMMUNITY REVIEWS

Regulatory B cells as inhibitors of immune responses and inflammation

(2008) Jean-David Bouaziz et al.   IMMUNOLOGICAL REVIEWS

Rituximab Exerts a Dual Effect in Pemphigus Vulgaris

(2008) Rüdiger Eming et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses

(2008) Hugo Mouquet et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

(2008) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines

(2008) Y. Tamimoto et al.   RHEUMATOLOGY

Pathophysiological aspects of memory B-cell development

(2007) Sandrine Roulland et al.   TRENDS IN IMMUNOLOGY